Reference:
Murphy SJ, Mayer L, Abreu MT. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis. J Clin Gastroenterol. 2011 Jan;45(1):83-4.
Poh J, Knowles S. Safety of 5-Aminosalicylic Acid Derivatives in Patients with Sensitivity to Acetylsalicylic Acid and Nonsteroidal Anti-inflammatory Drugs. Can J Hosp Pharm. 2014 Jan;67(1):35-8.
Nakashima J, Patel P, Preuss CV. Mesalamine (USAN) StatPearls [Internet]. ) [Updated 2024 Feb 15; cited 2024 Oct 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551714/
Kung SJ, Choudhary C, McGeady SJ, et al. Lack of cross-reactivity between 5-aminosalicylic acid-based drugs: a case report and review of the literature. Ann Allergy Asthma Immunol. 2006 Sep;97(3):284-7.
National Institutes of Health. Aspirin [Internet]. 2024 [cited 16 Oct 2024]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Aspirin
Bayer. ASPIRINÒ81 mg PACKAGE LEAFLET [Internet]. 2022 [cited 16 Oct 2024]. Available from: https://www.bayer.com/sites/default/files/2020-11/aspirin-pm-en.pdf
Greestone LLC. MESALAMINE PACKAGE LEAFLET [Internet]. 2022 [cited 16 Oct 2024]. Available from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=370bd908-55af-4dfc-8837-913bf73babbd&type=display
Keywords:
mesalamine, aspirin, แพ้ยา
